$AIOT

10 Fastest Growing Tech Penny Stocks to Buy

The article lists 10 “fastest growing” tech penny stocks under $5, using a Finviz screen for over 50% compounded annual revenue growth in 3 years and recent catalysts. It highlights PowerFleet (NASDAQ:AIOT) launching SafeGuard, reporting up to 83% on-road risk reduction, and approving a $30M repurchase. It also covers Geron (NASDAQ:GERN) granting 690,000 options at $1.23.

Original reporting
Published Jul 12, 2026, 10:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Jul 12, 2026, 10:04 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
10 Fastest Growing Tech Penny Stocks to Buy — source image
Decision brief

The 30-second read

$AIOTBullishLow
01

Why it matters

AIOT’s SafeGuard launch and buyback authorization are the most actionable items in the text. GERN’s disclosure is primarily compensation-related with limited trading implications.

02

Market read

Traders get concrete corporate updates for AIOT and a specific option-grant detail for GERN, but the article is not a fresh earnings or guidance catalyst.

03

What to watch

For AIOT, adoption metrics and customer retention matter more than reported reductions in risk. For GERN, hiring-related inducement options do not address pipeline timelines or trial readouts.

Relevance 4/10Novelty 4/10Timing: post-publication roundup of July 1 and June 18 disclosures

Background

The piece is a promotional-style list using a Finviz screen for tech stocks under $5 with high revenue growth, then adds “noteworthy developments” to justify inclusion.

Company-level read

Ticker impact

$AIOTBullishMedium confidence
Context

PowerFleet launched SafeGuard, an AI risk-intelligence add-on, and also disclosed a board-approved $30M buyback program.

Expected impact

Moderately positive bias over days to weeks, with upside capped by execution and adoption uncertainty.

Evidence & confidence

The article provides concrete launch details and a defined buyback authorization, but no new financial guidance numbers beyond an analyst’s improved FY27 outlook.

$GERNNeutralHigh confidence
Context

Geron granted 690,000 shares worth of stock options to newly hired employees at a $1.23 exercise price.

Expected impact

Limited price impact; any effect is likely small and short-lived.

Evidence & confidence

The disclosure is specific (option terms and exercise price) but does not include clinical, regulatory, or financial performance updates.

Market effects

Highlights continued investor focus on AI infrastructure and biotech innovation themes, but provides no new sector-wide data.

No specific regional macro or policy catalyst beyond PowerFleet’s APAC launch framing.

AI supply-chain and therapeutics innovation themes are globally relevant, but the article is company-specific without cross-market shocks.

Counterpoint

Stock-screen and “fastest growing penny stocks” framing can overstate investability; option grants and repurchase authorizations may not translate into near-term earnings power.

Key entities

  • PowerFleet, Inc.

    Launched SafeGuard AI risk-intelligence add-on and authorized up to $30M share repurchases.

  • Geron Corporation

    Granted inducement stock options to newly hired employees with specified exercise price and vesting.

Related articles

$GERNMed

Geron Q2 Earnings Call Highlights

Geron (NASDAQ:GERN) said about 8,000 U.S. patients may be eligible for RYTELO in second-line, lower-risk MDS. The company guided 2026 RYTELO net product revenue to the mid-to-high end of $220 million to $240 million and expects operating expenses of $230 million to $240 million. Q2 gross-to-net deductions rose to 20.7%.

$GERNMed

Geron Q2 2026: RYTELO Growth Support Guidance

Geron (GERN) reported Q2 2026 results, citing RYTELO (imetelstat) net product revenue of $57.5M, up 17% YoY. Net loss was $16.7M, slightly wider than $16.4M. Cash and marketable securities totaled $327M at June 30. For FY 2026, Geron guided RYTELO revenue of $220M to $240M and operating expenses of $230M to $240M. Wedbush reiterated an outperform rating and set a $6 price target.

$GERNMed

GERON CORP (GERN): Results of Operations and Financial Condition

GERON CORP (GERN) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 d158179dex991.htm EX-99.1 EX-99.1 Exhibit 99.1 Geron Corporation Reports Second Quarter 2026 Financial Results and Recent Business Highlights August 5, 2026 Achieved $57.5 million in RYTELO ® (imetelstat) net product revenue in Q2 2026, an increase of 11% compared to Q1

$GERNMedAI 8/10

Geron (GERN) Q2 2026 Earnings Call Transcript

Geron (GERN) reported Q2 2026 net revenue of $57.5 million, up 17% year over year and 11% sequentially, driven by RYTELO sales momentum. The company reiterated 2026 net product revenue guidance of $220 million to $240 million and total operating expense guidance of $230 million to $240 million. Cash was $327 million as of June 30, 2026.

$GERNMed

Geron Corp (GERN) (Q2 2026) Earnings Call Highlights: Strong Revenue Growth

Geron Corp (NASDAQ:GERN) reported Q2 2026 earnings call updates, citing 5% demand growth for RYTELO vs Q1 and an 8% rise in prescribing accounts to about 1,575 since launch. Full-year revenue guidance is $220 million to $240 million, with gross-to-net deductions at 20.7% in Q2. The company is evaluating changes to an interim analysis event threshold for its IMPACT MF trial.

$AIOTMed

Is PowerFleet (AIOT) the Fastest Growing Tech Penny Stocks to Buy?

PowerFleet (NASDAQ:AIOT) said it launched SafeGuard in Australia, an AI risk intelligence add-on to its VisionAI and Unity platform, to monitor on-road driver behavior. The company cited reported results including up to 83% lower on-road risk and 95% fewer false alerts. Its board approved a $30M repurchase program. Raymond James cut its price target to $7 from $8, keeping Outperform.